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Abstract
In this study, a microscale thermophoretic (MST) method was developed to
investigate lactoferrin-drug interaction using label-free system which depends on the
intrinsic fluorescence of one interacting partner. The interaction between lactoferrin
and the iron chelator deferiprone was first investigated to evaluate the excretion of
deferiprone into mother milk during lactation. Furthermore, the interaction between
lactoferrin and amphotericin B was investigated for possible explanation of the
observed synergistic effect as antifungal effect. The experiments were performed on
Monolith NT.115 LabelFree® (NanoTemper Technologies, Munich, Germany).
Different concentrations of the intended drugs in the range of 0.007- 250 μM were
titrated against 120 nM fixed concentration of lactoferrin which was dissolved in 0.1
M tris buffer at pH 7.4. The measurements were performed using standard capillaries
at 20% excitation power and medium MST power. The results indicated a significant
interaction between lactoferrin and deferiprone however, no significant interaction
between lactoferrin and amphotericin B was observed. The data were analyzed using
NT Analysis software which was provided by NanoTemper Technologies. The
estimated binding constant for lactoferrin-deferiprone interaction was (8.9 x 10 -6 ±
1.6 SD) which is reported for the first time. This significant binding between
lactoferrin and deferiprone may potentiates the drug secretion into mother milk. The
technique shows fast and simple approach to study protein-drug interaction without
complicated labelling procedures.
Overview
Lactoferrin (LF) is known as a multifunctional protein which possess antimicrobial,
antitumor, anti-inflammatory, protease inhibition and iron chelation effects 1. LF is present
in all biological fluids thus, it considered good protein target for interaction studies of drug
pharmacokinetics, drug efficacy and drug design 2,3. Deferiprone (CP20) -iron chelators- is
highlighted in several reports for treatment of many disease states such as infectious
diseases, cancers, neurodegenerative diseases 4,5. In contrast, LF provides synergism with
Amphotericin B (AmB) against several fungal species. However, the synergism is
attributed to protein-drug interaction which elaborate specific properties for antifungal
activity6,7. For this purpose, two different approaches were carried out to investigate LF-
drug interaction. First approach is study the interaction between LF and CP20 to predict the
drug excretion into mother milk as protein bounded fraction and second approach to
investigate the interaction between LF and AmB using label-free microscale
thermophoresis (MST). The technique is used to measure the molecular interactions
through temperature gradient in microscale size with no restriction to buffering system or
immobilization procedures 8,9.
Experimental
A. Instrument
The developed method was carried out using Monolith NT.115 LabelFree®
microscale thermophoresis (NonoTemper technologies, Munich, Germany).
Instrument principle and picture is shown in Figure 1.
B. Method
❖ All samples were prepared in 0.1 M Tris buffer and the pH was adjusted at
7.4.
❖ In each experimental set three different concentrations of each partner were
prepared for MST scanning thereafter, fixed concentration of LF were
selected according to the fluorescence signals in scanning test and serial
concentrations of drug were prepared for measurements. All sample
preparations summarized in Table 1.
❖ MST setting was summarized in Table 2. MST parameter Set
MST-Power: Medium 
Excitation-Power: 20%
Excitation type: Label-Free
Thermostat Setpoint: (disabled)
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MST scanning MST measurements
LF (target) 60, 120, 240 nM Fixed at: 120 nM
CP20 (ligand) 125, 250,500 nM Range of: 0.007 – 250 µM
AmB (ligand) 125, 250, 500 nM Range of: 0.007 – 250 µM
Tris Buffer 
(solvent)
0.1 M -
Data analysis:
The used MST is supported with analysis software to fit the data curve with
two different binding parameters KD (binding constant) or EC50 from Hill
equation.
Herein, KD from low of mass action fit with the obtained data as follow:
A + T↔ AT
F(CT) = Fu + (Fb- Fu) ×
𝐶𝐴𝑇
𝐶𝐴
Fraction bound =
1
2𝐶𝐴
× (𝐶𝑇 + 𝐶𝐴 + 𝐾𝑑 − 𝐶𝑇 + 𝐶𝐴 + 𝐾𝐷
2 − 4 𝐶𝑇𝐶𝐴
Fu Fluorescence in unbound state, Fb Fluorescence in bound state, KD Dissociation constant, CAT
Concentration of complex, CA Concentration of Molecule A (fluorescent) and CT Concentration of
titrated molecule
Results
❖ LF shows binding affinity to CP20 (Figure 2).
❖ LF-AmB thermophoretic curve shows no discrimination between bound
and unbound molecules (Figure 3)
❖ Dissociation constant (KD) was estimated as summarized in Table 3.
Fit Results (KD)
Fit Model: KD
Bound 857.596
Unbound 869.026
KD 8.9 × 10−6 ± 1.6𝑆𝐷
Target Conc. 0.000000121
KD Confidence: ±4.1× 10−6
Conclusion
The observed interaction between LF and CP20 predicts drug excretion into mother
milk as drug bounded fraction. No interaction was observed between LF and AmB
under the used MST conditions. Thus, the synergistic effect of LF-AmB is not
probably due to direct interaction between them. MST labelFree system provides
valuable information for binding behavior and exhibit flexibility to study the
molecular interactions without demand to extra labeling procedures.
Figure 1. Principle of MST 
Table 1. Sample preparation for different experimental sets. Table 2. MST setting.
Table 3. Calculated KD constant with statistical parameters.
Figure 3. Thermophoretic curve for LF-AmB.Figure 2. Binding curve for LF-CP20. 
